Mirna Therapeutics
Austin
About Mirna Therapeutics
Mirna Therapeutics, Inc. (Mirna) is a discovery-stage biopharmaceutical research and development company focused on miRNA-directed human oncology therapies. Featuring world-class research capabilities, a strong understanding of miRNA and cancer biology, and an expansive IP portfolio, Mirna Therapeutics is well-positioned to capitalize on the emerging field of miRNA-based therapeutics.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $109.9M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2015)
- Ticker: nasdaq:MIRN
- Website: mirnatherapeutics.com
- Phone: 5126815201
Industries & Categories
Biotechnology, Health Care, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/mirna-therapeutics-1024995 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.